InvestorsHub Logo
Followers 4
Posts 227
Boards Moderated 0
Alias Born 05/03/2018

Re: None

Wednesday, 05/23/2018 8:14:30 AM

Wednesday, May 23, 2018 8:14:30 AM

Post# of 425689
Hi Bio

Thanks for your post (and all the previous ones) and response to my question on the mineral oil placebo. I did some digging and found this class action here:

http://securities.stanford.edu/filings-documents/1051/AMRN00_01/2014919_r01c_13CV06663.pdf

Knowing your thoughts on what happened, I am sure you have seen it.. but


On page 24 it talks about what happened with the mineral oil placebo in relation to ANCHOR but also mentions that it wasn't changed for REDUCE-IT after FDA SPA review. I was curious do you see this as moot point now as we are so far advanced with REDUCE-IT or do you think the rumoured comments from Dr Nissen are relevant in the context of this document or are more just a case of sour grapes?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News